Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer | MedPage Today

Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer | MedPage Today: In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo